NDC 50474-782 – Bimzelx

Bimekizumab 320 mg/2mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC50474-782

Product details

Brand name
Bimzelx
Generic name
Bimekizumab
Labeler
UCB, Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA761151
Marketed since
December 5, 2024
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Bimzelx →

Package NDC codes (2)

Package NDCDescriptionSince
50474-782-841 SYRINGE, GLASS in 1 CARTON (50474-782-84) / 2 mL in 1 SYRINGE, GLASSDec 5, 2024
50474-782-861 SYRINGE, GLASS in 1 CARTON (50474-782-86) / 1 mL in 1 SYRINGE, GLASSDec 5, 2024

Other Bimzelx products